Franklin Resources Inc Karyopharm Therapeutics Inc. Transaction History

Franklin Resources Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $84,239 - $120,165	20,647 New	20,647 $112,000
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $167,879 - $249,876	-38,861 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$4.12 - $10.25 $7.25 Million - $18 Million	-1,760,835 Reduced 97.84%	38,861 $227,000
Q4 2018 Feb 12, 2019	SELL	$8.2 - $16.95 $330,599 - $683,373	-40,317 Reduced 2.19%	1,799,696 $16.9 Million
Q3 2018 Nov 13, 2018	SELL	$17.03 - $21.18 $4.48 Million - $5.58 Million	-263,243 Reduced 12.52%	1,840,013 $31.3 Million
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $615,264 - $1.02 Million	51,272 Added 2.5%	2,103,256 $35.7 Million
Q1 2018 May 10, 2018	SELL	$9.92 - $17.25 $12.8 Million - $22.2 Million	-1,285,585 Reduced 38.52%	2,051,984 $27.5 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $1.83 Million - $2.4 Million	200,310 Added 6.38%	3,337,569 $32 Million
Q3 2017 Nov 13, 2017	BUY	$8.15 - $11.16 $25.6 Million - $35 Million	3,137,259	3,137,259 $34.4 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $55.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.